UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1272) 1272
Newspaper Article (35) 35
Newsletter (9) 9
Book Chapter (6) 6
Magazine Article (5) 5
Dissertation (2) 2
Transcript (2) 2
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1038) 1038
lopinavir (1019) 1019
science & technology (926) 926
life sciences & biomedicine (864) 864
hiv infections - drug therapy (701) 701
male (622) 622
female (596) 596
infectious diseases (538) 538
adult (502) 502
ritonavir - administration & dosage (492) 492
ritonavir (403) 403
ritonavir - therapeutic use (377) 377
biological and medical sciences (360) 360
medical sciences (358) 358
antiviral agents (357) 357
pyrimidinones - administration & dosage (357) 357
pharmacology & pharmacy (348) 348
hiv (336) 336
middle aged (333) 333
hiv protease inhibitors - administration & dosage (315) 315
anti-hiv agents - administration & dosage (289) 289
drug therapy, combination (287) 287
viral diseases (278) 278
human immunodeficiency virus--hiv (277) 277
pharmacology. drug treatments (269) 269
drug combinations (260) 260
pyrimidinones - therapeutic use (257) 257
hiv protease inhibitors - therapeutic use (247) 247
drug therapy (246) 246
lopinavir - administration & dosage (246) 246
human viral diseases (234) 234
immunology (229) 229
treatment outcome (229) 229
anti-hiv agents - therapeutic use (226) 226
virology (220) 220
ritonavir - adverse effects (218) 218
antiretroviral drugs (214) 214
microbiology (214) 214
hiv infections - virology (212) 212
viral load (210) 210
protease inhibitors (206) 206
viral diseases of the lymphoid tissue and the blood. aids (204) 204
antibiotics. antiinfectious agents. antiparasitic agents (200) 200
aids/hiv (185) 185
lopinavir - therapeutic use (184) 184
hiv protease inhibitors - adverse effects (172) 172
ritonavir - pharmacokinetics (171) 171
drug administration schedule (164) 164
pyrimidinones - adverse effects (164) 164
hiv-1 - drug effects (160) 160
covid-19 (159) 159
dosage and administration (150) 150
hiv infection (150) 150
drug interactions (144) 144
health aspects (144) 144
hiv protease inhibitors - pharmacokinetics (141) 141
pyrimidinones - pharmacokinetics (139) 139
coronaviruses (134) 134
cd4 lymphocyte count (133) 133
pharmacokinetics (131) 131
research (128) 128
antiretroviral therapy (127) 127
antiretroviral therapy, highly active (125) 125
clinical trials (125) 125
adolescent (123) 123
immunodeficiencies (121) 121
immunodeficiencies. immunoglobulinopathies (121) 121
immunopathology (121) 121
young adult (120) 120
tenofovir (119) 119
anti-hiv agents - adverse effects (117) 117
anti-hiv agents - pharmacokinetics (115) 115
virus diseases (113) 113
analysis (110) 110
highly active antiretroviral therapy (110) 110
animals (109) 109
lopinavir/ritonavir (108) 108
aged (107) 107
pharmacology (107) 107
hiv-1 (106) 106
patients (104) 104
human immunodeficiency virus (103) 103
lopinavir - pharmacokinetics (100) 100
pandemics (100) 100
ritonavir - pharmacology (100) 100
drugs (96) 96
child (94) 94
aids (93) 93
sars-cov-2 (90) 90
infant (89) 89
lopinavir - adverse effects (89) 89
atazanavir sulfate (87) 87
proteases (82) 82
care and treatment (81) 81
hiv protease inhibitors - pharmacology (81) 81
abridged index medicus (80) 80
hiv infections - blood (78) 78
rna, viral - blood (78) 78
anti-hiv agents (76) 76
reverse transcriptase inhibitors - administration & dosage (76) 76
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1276) 1276
Spanish (30) 30
German (22) 22
Japanese (5) 5
Portuguese (5) 5
French (4) 4
Russian (4) 4
Chinese (3) 3
Hungarian (1) 1
Italian (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of thrombosis and haemostasis, ISSN 1538-7933, 06/2020, Volume 18, Issue 6, pp. 1320 - 1323
plasma level | anticoagulant | COVID‐19 | antiviral agents | DOAC | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Betacoronavirus - pathogenicity | Dabigatran - adverse effects | Dabigatran - administration & dosage | Coronavirus Infections - drug therapy | Humans | Pneumonia, Viral - drug therapy | Male | Antithrombins - administration & dosage | Pyridones - blood | Thiazoles - adverse effects | Factor Xa Inhibitors - administration & dosage | COVID-19 | Pyridines - adverse effects | SARS-CoV-2 | Drug Interactions | Factor Xa Inhibitors - blood | Pyrazoles - blood | Patient Safety | Aged, 80 and over | Pyridines - administration & dosage | Risk Assessment | Administration, Oral | Risk Factors | Antiviral Agents - administration & dosage | Coronavirus Infections - virology | Antiviral Agents - adverse effects | Factor Xa Inhibitors - adverse effects | Antithrombins - blood | Pneumonia, Viral - diagnosis | Italy | Darunavir - adverse effects | Hemorrhage - chemically induced | Thiazoles - blood | Pandemics | Thiazoles - administration & dosage | Pyridones - administration & dosage | Ritonavir - adverse effects | Female | Pyrazoles - adverse effects | Severity of Illness Index | Coronavirus Infections - diagnosis | Betacoronavirus - drug effects | Dabigatran - blood | Pyrazoles - administration & dosage | Pyridines - blood | Antithrombins - adverse effects | Aged | Drug Monitoring | Pneumonia, Viral - virology | Lopinavir - adverse effects | Pyridones - adverse effects | Anticoagulants | Plasma | Antiviral agents | Ritonavir | Lopinavir | Plasma levels | Hospitalization | Patients | Thrombosis | Index Medicus
Journal Article
AIDS (London), ISSN 0269-9370, 09/2007, Volume 21, Issue 14, pp. 1899 - 1907
Women | Genital tract | HIV | Prophylaxis | Sexual transmission | Pharmacokinetics | Antiretroviral therapy | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Virology | Antiviral agents | General aspects | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Antibiotics. Antiinfectious agents. Antiparasitic agents | Epidemiology. Vaccinations | Lamivudine - administration & dosage | Humans | Deoxycytidine - blood | Zidovudine - administration & dosage | Tenofovir | Deoxycytidine - pharmacokinetics | HIV Protease Inhibitors - pharmacokinetics | Atazanavir Sulfate | Genitalia, Female - metabolism | Emtricitabine | HIV Infections - blood | HIV Protease Inhibitors - blood | Adenine - analogs & derivatives | Pyridines - administration & dosage | Benzoxazines - administration & dosage | Administration, Oral | Anti-Retroviral Agents - pharmacokinetics | Deoxycytidine - administration & dosage | Lopinavir | HIV Protease Inhibitors - administration & dosage | Adenine - pharmacokinetics | Pyrimidinones - blood | Anti-Retroviral Agents - administration & dosage | Oligopeptides - administration & dosage | Pyrimidinones - administration & dosage | Zidovudine - blood | Deoxycytidine - analogs & derivatives | Reverse Transcriptase Inhibitors - blood | Zidovudine - pharmacokinetics | Pyridines - pharmacokinetics | Reverse Transcriptase Inhibitors - administration & dosage | Adenine - blood | Reverse Transcriptase Inhibitors - pharmacokinetics | Benzoxazines - pharmacokinetics | Adult | Benzoxazines - blood | Female | Organophosphonates - blood | Anti-Retroviral Agents - blood | Drug Therapy, Combination | Oligopeptides - blood | Oligopeptides - pharmacokinetics | Lamivudine - blood | Lamivudine - pharmacokinetics | Adenine - administration & dosage | Organophosphonates - pharmacokinetics | Organophosphonates - administration & dosage | Pyridines - blood | Pyrimidinones - pharmacokinetics | HIV Infections - drug therapy | Index Medicus | AIDS/HIV | genital tract | sexual transmission | antiretroviral therapy | pharmacokinetics | prophylaxis | women
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 08/2008, Volume 52, Issue 7, pp. 569 - 576
endothelial function | human immunodeficiency virus | cardiovascular disease risk | antiretroviral therapy | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Antiviral agents | Immunopathology | Viral diseases | Biological and medical sciences | Medical sciences | Immunodeficiencies | Cardiology. Vascular system | Infectious diseases | Pharmacology. Drug treatments | Viral diseases of the lymphoid tissue and the blood. Aids | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Antibiotics. Antiinfectious agents. Antiparasitic agents | HIV-1 | Lamivudine - administration & dosage | Prospective Studies | Humans | Endothelium, Vascular - drug effects | Male | Stavudine - administration & dosage | Reverse Transcriptase Inhibitors - administration & dosage | Zidovudine - administration & dosage | Anti-HIV Agents - administration & dosage | Tenofovir | Time Factors | Adult | Brachial Artery - physiopathology | Female | Brachial Artery - drug effects | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Ritonavir - administration & dosage | Lopinavir | CD4 Lymphocyte Count | HIV Protease Inhibitors - administration & dosage | Adenine - administration & dosage | Organophosphonates - administration & dosage | Endothelium, Vascular - pathology | HIV Infections - drug therapy | Pyrimidinones - administration & dosage | HIV Infections - physiopathology | Studies | Ultrasonic imaging | Human immunodeficiency virus--HIV | Deflation | Aging | Clinical trials | Infections | Diabetes | Drug therapy | Risk factors | Cholesterol | Veins & arteries | Index Medicus | Abridged Index Medicus
Journal Article
AIDS (London), ISSN 0269-9370, 2013, Volume 27, Issue 5, pp. 803 - 813
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Virology | Antiviral agents | Immunopathology | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Antibiotics. Antiinfectious agents. Antiparasitic agents | HIV-1 | United States - epidemiology | Lamivudine - administration & dosage | Humans | HIV Seropositivity - mortality | HIV Seropositivity - drug therapy | Nevirapine - adverse effects | Reverse Transcriptase Inhibitors - administration & dosage | Anti-HIV Agents - administration & dosage | Lamivudine - adverse effects | Reverse Transcriptase Inhibitors - adverse effects | Tenofovir | Adenine - adverse effects | Time Factors | Deoxycytidine - adverse effects | HIV Infections - mortality | Dideoxynucleosides - adverse effects | Antiretroviral Therapy, Highly Active - methods | Dideoxynucleosides - administration & dosage | Emtricitabine | HIV Protease Inhibitors - adverse effects | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | Risk Factors | Organophosphonates - adverse effects | Europe - epidemiology | Benzoxazines - adverse effects | HIV Protease Inhibitors - administration & dosage | Adenine - administration & dosage | Organophosphonates - administration & dosage | Lopinavir - administration & dosage | HIV Infections - drug therapy | Nevirapine - administration & dosage | Deoxycytidine - analogs & derivatives | Drug Combinations | Lopinavir - adverse effects | Cohort Studies | Index Medicus | AIDS/HIV
Journal Article
Journal Article
Journal Article
Pharmacotherapy, ISSN 0277-0008, 05/2020, Volume 40, Issue 5, pp. 416 - 437
dialysis | renal | antivirals | cytochrome P450 | infectious disease | liver | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Pandemics | Alanine - adverse effects | Adrenal Cortex Hormones | Coronavirus Infections - drug therapy | Humans | Pneumonia, Viral - drug therapy | Thiazoles - administration & dosage | Hydroxychloroquine - adverse effects | Thiazoles - adverse effects | Alanine - analogs & derivatives | Alanine - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Ritonavir - adverse effects | Ribavirin - administration & dosage | Betacoronavirus | Antibodies, Monoclonal, Humanized - adverse effects | Ritonavir - administration & dosage | Immunomodulation | Azetidines - adverse effects | Chloroquine - adverse effects | Antiviral Agents - administration & dosage | Adenosine Monophosphate - adverse effects | Hydroxychloroquine - administration & dosage | Nelfinavir - adverse effects | Interferon-alpha - administration & dosage | Azetidines - administration & dosage | Ribavirin - adverse effects | Adenosine Monophosphate - administration & dosage | Adenosine Monophosphate - analogs & derivatives | Antiviral Agents - adverse effects | Coronavirus Infections - therapy | Immunization, Passive | Lopinavir - administration & dosage | Sulfonamides - adverse effects | Chloroquine - administration & dosage | Interferon-alpha - adverse effects | Nelfinavir - administration & dosage | Drug Combinations | Lopinavir - adverse effects | Sulfonamides - administration & dosage | Severe acute respiratory syndrome coronavirus 2 | COVID-19 | Antiviral agents | Therapeutic applications | Clinical trials | Coronaviruses | Drug therapy | Patients | Index Medicus | Reviews of Therapeutics | Review of Therapeutics
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2006, Volume 368, Issue 9534, pp. 476 - 482
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Immunopathology | General aspects | Infectious diseases | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Dideoxynucleosides - administration & dosage | Organophosphates - administration & dosage | Lamivudine - administration & dosage | Ritonavir - administration & dosage | HIV-1 - drug effects | Humans | Lopinavir | Pyrimidinones - therapeutic use | Organophosphates - therapeutic use | Carbamates - administration & dosage | HIV Protease Inhibitors - administration & dosage | HIV-1 - genetics | Reverse Transcriptase Inhibitors - administration & dosage | HIV Protease Inhibitors - therapeutic use | Sulfonamides - therapeutic use | Lamivudine - therapeutic use | Ritonavir - therapeutic use | HIV Infections - drug therapy | Dideoxynucleosides - therapeutic use | Pyrimidinones - administration & dosage | Reverse Transcriptase Inhibitors - therapeutic use | Carbamates - therapeutic use | Drug Therapy, Combination | Sulfonamides - administration & dosage | Dosage and administration | Protease inhibitors | Comparative analysis | Drug therapy | HIV infection | Antiviral agents | Research | Drug therapy, Combination | Health aspects | Anti-HIV agents | Antiretroviral drugs | Human immunodeficiency virus--HIV | Samples | Clinical trials | Comparative studies | Clinical medicine | Disease control | Index Medicus | Abridged Index Medicus
Journal Article